Jennison Associates’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-993,253
Closed -$10.3M 578
2023
Q1
$10.3M Sell
993,253
-787,002
-44% -$9.27M 0.01% 388
2022
Q4
$19.6M Buy
1,780,255
+162,989
+10% +$2.1M 0.02% 326
2022
Q3
$25.1M Buy
1,617,266
+1,295,173
+402% +$28.5M 0.03% 283
2022
Q2
$7.39M Sell
322,093
-927,128
-74% -$19.8M 0.01% 412
2022
Q1
$30.8M Buy
1,249,221
+132,704
+12% +$3M 0.02% 295
2021
Q4
$30.5M Buy
1,116,517
+805,036
+258% +$28.2M 0.02% 292
2021
Q3
$13.3M Buy
+311,481
New +$13.8M 0.01% 417

Other funds holding DH

Jennison Associates's DH Position: Q2 2023 in Review

Jennison Associates sold out of Definitive Healthcare (DH) in Q2 2023, closing a stake of 993,253 shares — an estimated $10.3M sold.

Jennison Associates first reported a position in DH in Q3 2021 and held it in 7 quarters. The position peaked at $30.8M in Q1 2022. 137 funds tracked by Wall St. Rank hold DH as of Q2 2023.

  • Jennison Associates reported no remaining Definitive Healthcare position as of Q2 2023 after selling out during the quarter.
  • Jennison Associates sold 993,253 Definitive Healthcare shares in Q2 2023, an estimated $10.3M.
  • Jennison Associates first reported a position in Definitive Healthcare in Q3 2021 and held it in 7 quarters.
  • Jennison Associates's Definitive Healthcare position peaked at $30.8M in Q1 2022.
  • 137 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2023.

Based on Jennison Associates's 13F filing for Q2 2023, filed 3 Aug 2023.